The overlooked COST of multiple myeloma

Lancet Haematol. 2015 Oct;2(10):e394-5. doi: 10.1016/S2352-3026(15)00192-1. Epub 2015 Sep 17.

Authors

Jonas A de Souza¹, Lori Muffly²

Affiliations

¹ University of Chicago Medicine, Department of Medicine, 5841 S Maryland Av, Chicago, IL 60637, USA. Electronic address: [email protected].
² Stanford University, Division of Blood and Marrow Transplantation, Stanford, CA, USA.

PMID: 26686034
DOI: 10.1016/S2352-3026(15)00192-1

No abstract available

Publication types

Comment

MeSH terms

Cost-Benefit Analysis*
Humans
Multiple Myeloma*